Our work indicated that IL-6 gene -174C-allele carriers are significantly associated with increasing NSCLC risk, whereas the IL-1β-511(CT) heterozygote genotype showed a protective role for NSCLC incidence. This evidence concerns the gene IL1B and non-small cell lung carcinoma.